NCT04788108View on ClinicalTrials.gov

Oral Progesterone for Prevention of Miscarriage in Threatened Abortion

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Threatened Abortion
Interventions
DRUG

Dydrogesterone

Dydrogesterone tablet

DRUG

Placebo

Placebo tablet

Trial Locations (1)

10330

Faculty of Medicine, Chulalongkorn University, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT04788108 - Oral Progesterone for Prevention of Miscarriage in Threatened Abortion | Biotech Hunter | Biotech Hunter